Abnormal α-synuclein interactions with rab proteins in α-synuclein A30P transgenic mice

被引:80
作者
Dalfó, E
Gómez-Isla, T
Rosa, JL
Bodelón, MN
Tejedor, MC
Barrachina, M
Ambrosio, S
Ferrer, I
机构
[1] Hosp Univ Bellvitge, Serv Anat Patol, Inst Neuropatol, Hosp Llobregat, Barcelona 08907, Spain
[2] Univ Barcelona, Dept Biol Cellular & Anat Patol, Unitat Neuropatol Expt, Barcelona, Spain
[3] Univ Barcelona, Hosp Llobregat, Dept Ciencias Fisiol 2, Unitat Bioquim, Barcelona, Spain
[4] Univ Navarra, Dept Neurol, Navarra, Spain
关键词
alpha-synuclein; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); Parkinson disease; Rab3a; Rab5; Rab8; rotenone;
D O I
10.1093/jnen/63.4.302
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutation A30P in the a-synuclein gene is a cause of familial Parkinson disease. Transgenic mice expressing wild mouse and mutant human A30P alpha-synuclein, Tg5093 mice (Tg), show a progressive motor disorder characterized by tremor, rigidity, and dystonia, accompanied by accumulation of alpha-synuclein in the soma and neurites and by a conspicuous gliosis beginning in the hippocampal formation at the age of 7 to 8 months and spreading throughout the CNS. Impaired short-term changes in synaptic strength have also been documented in hippocampal slices from Tg mice. alpha-synuclein aggregates of approximately 34 and 70 kDa, in addition to the band of 17 kDa, corresponding to the molecular weight of a-synuclein, were recovered in the PBS-soluble fraction of brain homogenates from Tg mice but not from brain samples from age-matched wildtype littermates. MPTP-treated Tg and wildtype mice produced alpha-synuclein aggregates in the PBS-, deoxycholate-, and SDS-soluble fractions. Aggregates of alpha-synuclein, although with different molecular weights, were also observed in rotenone-treated Tg and wildtype mice. Pull-down studies with members of the Rab protein family have shown that a-synuclein from Tg mice interacts with Rab3a, Rab5, and Rab8. This binding is not due to the amount of alpha-synuclein (levels of which are higher in Tg mice) and it is not dependent on the amount of Rab protein used in the assay. Rather, alpha-synuclein interactions with Rab proteins are due to mutant (x-synuclein as demonstrated in Rab pull-down assays with recombinant of wildtype and mutant A30P human alpha-synuctein. Since Rab3a, Rab5, and Rab8 are important proteins involved in synaptic vesicle trafficking and exocytosis at the synapse, vesicle endocytosis, and trans-Golgi transport, respectively, it can be suggested that these functions are impaired in Tg mice. This rationale is consistent with previous data showing that short-term hippocampal synaptic plasticity is altered and that a.-synuclein accumulates in the cytoplasm of neurons in Tg mice.
引用
收藏
页码:302 / 313
页数:12
相关论文
共 58 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   Chronic systemic pesticide exposure reproduces features of Parkinson's disease [J].
Betarbet, R ;
Sherer, TB ;
MacKenzie, G ;
Garcia-Osuna, M ;
Panov, AV ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2000, 3 (12) :1301-1306
[3]  
Cabin DE, 2002, J NEUROSCI, V22, P8797
[4]   The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease [J].
Clayton, DF ;
George, JM .
TRENDS IN NEUROSCIENCES, 1998, 21 (06) :249-254
[5]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[6]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[7]   Widespread alterations of α-synuclein in multiple system atrophy [J].
Dickson, DW ;
Liu, WK ;
Hardy, J ;
Farrer, M ;
Mehta, N ;
Uitti, R ;
Mark, M ;
Zimmerman, T ;
Golbe, L ;
Sage, J ;
Sima, A ;
D'Amato, C ;
Albin, R ;
Gilman, S ;
Yen, SH .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1241-1251
[8]   Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease [J].
El-Agnaf, OMA ;
Jakes, R ;
Curran, MD ;
Wallace, A .
FEBS LETTERS, 1998, 440 (1-2) :67-70
[9]   α-synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy [J].
Gai, WP ;
Pountney, DL ;
Power, JHT ;
Li, QX ;
Culvenor, JG ;
McLean, CA ;
Jensen, PH ;
Blumbergs, PC .
EXPERIMENTAL NEUROLOGY, 2003, 181 (01) :68-78
[10]   Synucleinopathies - Clinical and pathological implications [J].
Galvin, JE ;
Lee, VMY ;
Trojanowski, JQ .
ARCHIVES OF NEUROLOGY, 2001, 58 (02) :186-190